share_log

Avalo Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

SEC announcement ·  Oct 5, 2023 16:02
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more